Showing results (1031-1040 of 1,179) with videos related to

Sort By:
Pageof 118
Plos One|September 13, 2019
Generation of a protective murine monoclonal antibody against the stem of influenza hemagglutinins from group 1 viruses and identification of resistance mutations against itWei Wang, Russell Vassell, Hyo Sook Song, et al.
The American Journal of Managed Care|June 4, 2013
Prescription opioid abuse: challenges and opportunities for payersNathaniel P Katz, Howard Birnbaum, Michael J Brennan, et al.
Neurology|October 23, 2016
Death with dignity in Washington patients with amyotrophic lateral sclerosisLeo H Wang, Michael A Elliott, Lily Jung Henson, et al.
Comparative Medicine|April 7, 2017
Effects of Racecadotril on Weight Loss and Diarrhea Due to Human Rotavirus in Neonatal Gnotobiotic Pigs (Sus scrofa domesticus)Tammy Bui, Guohua Li, Inyoung Kim, et al.
Pediatric Blood & Cancer|October 17, 2023
Gadolinium-based contrast media does not improve the staging of neuroblastoma image-defined risk factors at diagnosisCara E Morin, Reem Hasweh, Chris Anton, et al.
Nature|November 24, 2006
Magnetic vortex core reversal by excitation with short bursts of an alternating fieldB Van Waeyenberge, A Puzic, H Stoll, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|December 2, 2020
Tet1 Isoforms Differentially Regulate Gene Expression, Synaptic Transmission, and Memory in the Mammalian BrainC B Greer, J Wright, J D Weiss, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 5, 2008
U.S. Food and Drug Administration approval: panitumumab for epidermal growth factor receptor-expressing metastatic colorectal carcinoma with progression following fluoropyrimidine-, oxaliplatin-, and irinotecan-containing chemotherapy regimensRuthann M Giusti, Kaushikkumar Shastri, Anne M Pilaro, et al.
Contemporary Clinical Trials|January 22, 2025
Optimizing retention strategies for opioid use disorder pharmacotherapy: The retention phase of the CTN-0100 trial (RDD)Matisyahu Shulman, Sarah Meyers-Ohki, Patricia Novo, et al.
Psychiatric Services (Washington, D.C.)|May 3, 2011
International variation in treatment procedures for ADHD: social context and recent trendsStephen P Hinshaw, Richard M Scheffler, Brent D Fulton, et al.
Pageof 118